Products

What will AGI do for Alvimopan?

This classification denotes an opiate antagonist with the molecular formula C25H32N2O4.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 677C126AET, chemically known as glycine, n-((2s)-2-(((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, dihydrate but generally known as alvimopan, which bears US NIH Compound Identifier 5488547. Alvimopan most often comes in simple, anhydrous, and hyrdate forms. European Medicines Agency schedules Alvimopan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20585. World Health Organization schedules alvimopan in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule alvimopan under HS 29333999 and SITC 51574. As of Q4 2014, ALVIMOPAN remains the US FDA Preferred Term for this commodity. Alvimopan bears US NLM identifiers UMLS ID C1508750 and NCI Concept Code C49096. SMILES: OC1CC(C2(C(CN(CC2)CC(CC2CCCCC2)C(=O)NCC(=O)O)C)C)CCC1.O.O.